ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September

April 5, 1985

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983